Please note that this product was withdrawn from the Union Register of orphan medicinal products in November 2020 on request of the Sponsor.

On 24 April 2015, orphan designation (EU/3/15/1474) was granted by the European Commission to JJGConsultancy Ltd, United Kingdom, for ecothiopate iodide for the treatment of Stargardt's disease.

Key facts

Active substance
Ecothiopate iodide
Disease / condition
Treatment of Stargardt's disease
Date of first decision
EU designation number

Review of designation

The Committee for Orphan Medicinal Products reviews the orphan designation of a product if it is approved for marketing authorisation.

Sponsor's contact details

JJGConsultancy Ltd
Sherston House
High Street
Somerset BA4 6HZ
United Kingdom
Tel. +44 (0)1749 838886
Fax +44 (0)1749 838887

Patients' organisations

For contact details of patients’ organisations whose activities are targeted at rare diseases, see:

  • European Organisation for Rare Diseases (EURORDIS), a non-governmental alliance of patient organisations and individuals active in the field of rare diseases.

  • Orphanet, a database containing information on rare diseases, which includes a directory of patients’ organisations registered in Europe.

How useful was this page?

Add your rating